Effect of endothelin and endothelin receptor blockade on capillary permeability in experimental pancreatitis

Abstract

Background: Capillary leakage with fluid loss into the third space contributes to many of the early systemic complications in severe acute pancreatitis. There has been increasing interest in endothelin as one of the factors affecting capillary permeability.

Aim: To elucidate further the role of endothelin in the development of capillary leakage in acute pancreatitis by investigating the effect of exogenous endothelin administration and endothelin receptor blockade in sham operated animals and two models of acute pancreatitis.

Methods: Determination of capillary permeability in the pancreas and colonic mucosa by quantifying extravasation of fluorescein labelled dextran using a novel computer assisted video image analysis system.

Results: Pancreatic and colonic capillary permeability increased stepwise from mild to severe acute pancreatitis. Endothelin increased pancreatic and colonic capillary permeability in healthy animals and animals with mild acute pancreatitis but had no additional adverse effect in severe acute pancreatitis. Endothelin receptor blockade decreased pancreatic capillary permeability in sham operated rats but had no effect on the colon. In mild and severe acute pancreatitis, endothelin receptor blockade stabilised increased capillary permeability in both the pancreas and colon.

Conclusions: Endothelin plays an important role in mediating capillary permeability in the pancreas. In severe pancreatitis, it increases capillary permeability even outside the pancreas, thereby contributing to capillary leakage. Endothelin receptor blockade significantly reduces capillary permeability in acute pancreatitis both in and outside the pancreas, suggesting a therapeutic approach to counteract capillary leakage in severe acute pancreatitis.

Figure 1

Effect of endothelin-1 (ET-1) and endothelin receptor antagonist (ET-RA) on capillary permeability (measured as the increase in perivascular density (%) 30 minutes after injection of fluorescein isothiocyanate labelled dextran 150) in the pancreas (A) and colon (B) of sham operated animals and animals with mild (EP) or severe (NP) acute pancreatitis. *p<0.05 compared with saline injected animals (Sal).

Figure 2

Capillary permeability (measured as the increase in perivascular density (%) 30 minutes after injection of fluorescein isothiocyanate labelled dextran 150) in the pancreas and colon of untreated sham operated animals (no acute pancreatitis) and animals with mild (EP) or severe (NP) acute pancreatitis. *p<0.05 v sham operated; †p<0.05 v EP.